163 related articles for article (PubMed ID: 2917583)
1. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy of recurrences of gynecologic carcinomas.
Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of RIS with the 131I-OC 125 F(ab')2 Mab and CT scan prior to second look operation for ovarian cancer.
Papazefkos V; Michalas S; Papantoniou V; Datseris J; Athanasiadis P; Akrivos T; Leonti A; Xygakis A; Aravantinos D
Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):271-7. PubMed ID: 2227070
[TBL] [Abstract][Full Text] [Related]
4. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
Zalutsky MR; Bast RC; Knapp RC
Int J Rad Appl Instrum B; 1989; 16(4):405-11. PubMed ID: 2777582
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
7. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
[TBL] [Abstract][Full Text] [Related]
9. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
[No Abstract] [Full Text] [Related]
10. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
[TBL] [Abstract][Full Text] [Related]
11. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.
Zalutsky MR; Knapp RC; Bast RC
Int J Rad Appl Instrum B; 1988; 15(4):431-7. PubMed ID: 3255739
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study.
Crippa F; Presti M; Marini A; D'Onofrio B; Bolis G; Buraggi GL
Int J Biol Markers; 1990; 5(3):103-8. PubMed ID: 2286774
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
14. [REGAJ diagnosis of recurrence of ovarian cancer].
Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
[No Abstract] [Full Text] [Related]
15. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.
Muto MG; Lepisto EM; Van den Abbeele AD; Knapp RC; Kassis AI
Am J Obstet Gynecol; 1989 Nov; 161(5):1206-12. PubMed ID: 2686446
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
[TBL] [Abstract][Full Text] [Related]
17. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
18. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer.
Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG
Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555
[TBL] [Abstract][Full Text] [Related]
19. Immunoscintigraphy of endometriosis.
Kennedy SH; Mojiminiyi OA; Soper ND; Shepstone BJ; Barlow DH
Br J Obstet Gynaecol; 1990 Aug; 97(8):667-70. PubMed ID: 2400745
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoscintigraphy in patients with ovarian cancer.
Kalofonos HP; Karamouzis MV; Epenetos AA
Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
